« Previous
Next »
Seminars in Thoracic and Cardiovascular Surgery
Volume 14, Issue 3
, Pages 268-274
, July 2002
PET scanning and the solitary pulmonary nodule
References
- . Small solitary pulmonary nodules. Radiol Clin North Am. 2000;38:471–478
- . Evaluation and management of the solitary pulmonary nodule. Am J Respir Crit Care Med. 2000;162:782–787
- Solitary pulmonary nodules: Part I. Morphologic evaluation for the differentiation of benign and malignant lesions. Radiographics. 2000;20:43–58
- . Solitary pulmonary nodules: Part II. Evaluation of the indeterminate nodule. Radiographics. 2000;20:59–66
- . The solitary pulmonary nodule: Ten-year follow-up of Veterans Administration Armed Forces Cooperative Study. Arch Surg. 1975;110:570–575
- The coin lesion story: Update 1976, twenty years’ experience with early thoracotomy for 179 suspected malignant coin lesions. Chest. 1976;70:332–336
- Solitary pulmonary nodules: CT assessment. Radiology. 1986;160:307–312
-
The solitary pulmonary nodule: Assessment, diagnosis, and management.
Chest. 1987;91:28–33
- An integrated approach to evaluation of the solitary pulmonary nodule. Mayo Clin Proc. 1990;65:173–186
- Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7–33
- Cancer Statistics 1997. CA Cancer J Clin. 1997;47:5–27
-
.
NCI.
http://prg.nci.nih.gov/lung/final report/htmlAugust 2001;
- . CT screening for lung cancer: Not ready for routine practice. Radiology. 2001;221:587–591
- The (14 C) deoxyglucose method for the measurement of local glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897–916
-
Labeled 2-deoxy-D-glucose analogs: 18 F labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14 C-2-deoxy-2-fluoro-D-glucose.
J Labeled Compds Radiopharmacol. 1978;14:175–183
- Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-deoxy-D-glucose: Validation of method. Ann Neurol. 1977;6:371–388
-
The [18 F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man.
Circ Res. 1979;44:117–127
- Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol. 1980;238:E69–E82
- . Enzymology of cancer cells. N Engl J Med. 1977;296:541–551
-
.
Principles of Biochemistry.
In: ed 5. New York,: McGraw-Hill; 1973;p. 441;
Chapter 6
- Solitary pulmonary nodules: Detection of malignancy with PET with 2-[f-18]-fluoro-2-deoxy-d-glucose. Radiology. 1992;184:441–444
- Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules: Potential role in evaluation and management. Chest. 1993;104:997–1002
- Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology. 1993;188:487–490
-
.
Multicenter prospective study of FDG-PET in the evaluation of indeterminate solitary pulmonary nodules.
J Nucl Med. 1995;36:94P;
(abstr)
- PET-FDG imaging and transthoracic needle lung biopsy in the evaluation of pulmonary lesions suspected to be malignant: A comparative risk-benefit analysis. Chest. 1995;108:441–446
- Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg. 1995;60:1348–1352
- Evaluation of the solitary pulmonary nodule by positron emission tomography imaging. Eur Respir J. 1996;9:410–414
- Likelihood of malignancy in a solitary pulmonary nodule: Comparison of bayesian analysis and result of FDG-PET scan. Chest. 1997;112:416–422
- Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol. 1998;16:1075–1084
- Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis. JAMA. 2001;285:914–924
- . Comparative effficacy of Positron Emission Tomography with Fluorodeoxyglucose in Evaluation of small (<1 cm), intermediate (1 to 3 cm) and large (>3 cm) lymph node lesions. Chest. 2000;117:773–778
- Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest. 1998;114:1105–1111
- Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412–1417
-
.
Positron emission tomography for mediastinal staging in non-small cell lung cancer; a meta-analysis.
Am J. Respir Crit Care Med. 1998;157:A256;
(abstr)
- Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-smll cell lung cancer; a prospective analysis of 50 cases. Chest. 1997;112:1480–1486
☆ Address reprint requests to James W. Fletcher, MD, Indiana University Hospital, Room 0655A, 550 North University Blvd, Indianapolis, IN 46202.
PII: S1043-0679(02)70044-0
« Previous
Next »
Seminars in Thoracic and Cardiovascular Surgery
Volume 14, Issue 3
, Pages 268-274
, July 2002
